BamSEC and AlphaSense Join Forces
Learn More

Boundless Bio Inc.

NASDAQ: BOLD    
Share price (1/9/26): $1.31    
Market cap (1/9/26): $29.3 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3(B)
from 10-Q 5 pages First Amendment to Lease
12/34/56
EX-10.3(A)
from 10-Q 42 pages Lease Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Boundless Bio, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.9
from 10-K 7 pages January 27, 2025 Robert Doebele, MD Phd
12/34/56
EX-10.8
from 10-K 6 pages You Are Currently a Party to an Employment Offer Letter With Boundless Bio, Inc. (The “Company”) Dated April 27, 2021 (The “Prior Agreement”). You and the Company Hereby Agree to Amend and Restate the Prior Agreement to Memorialize the Terms of Your Continued Employment With the Company, as Provided in This Amended and Restated Employment Letter Agreement (This “Amended Agreement”), Effective as of the Date on Which the Company Consummates Its Initial Public Offering (“Ipo”)
12/34/56
EX-10.1
from 10-Q 8 pages Severance Agreement and Release of All Claims 1
12/34/56
EX-10.1
from 10-Q 4 pages Boundless Bio, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.3
from S-8 16 pages Boundless Bio, Inc. 2024 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-8 19 pages Boundless Bio, Inc. 2024 Incentive Award Plan
12/34/56
EX-10.19
from S-1/A 17 pages Indemnification and Advancement Agreement
12/34/56
EX-10.4
from S-1/A 3 pages Boundless Bio, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.3
from S-1/A 16 pages Boundless Bio, Inc. 2024 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 34 pages Boundless Bio, Inc. 2024 Incentive Award Plan
12/34/56
EX-10.20
from S-1 5 pages Boundless Bio, Inc. Policy for Recovery of Erroneously Awarded Compensation
12/34/56
EX-10.18
from S-1 4 pages Boundless Bio, Inc. Corporate Bonus Plan
12/34/56
EX-10.17
from S-1 36 pages Boundless Bio, Inc. Severance and Change in Control Severance Plan and Summary Plan Description
12/34/56
EX-10.16
from S-1 5 pages March 5, 2024 Jessica Oien Re: Amended and Restated Employment Offer Letter Dear Jessica: • Base Salary. From and After the Ipo, You Will Receive an Annual Base Salary Increase to the Annual Base Salary Rate Approved by the Board and Communicated to You in a Separate Compensation Memorandum, for All Hours Worked, to Be Paid in Accordance With the Company’s Customary Payroll Procedures
12/34/56
EX-10.15
from S-1 9 pages June 23, 2021 Jessica Oien Re: Employment Offer Letter Dear Jessica: Boundless Bio, Inc. (The “Company”) Is Pleased to Offer You a Position on the Terms Set Forth in This Letter (This “Agreement”). • Base Salary. You Will Receive an Annual Base Salary of $345,000 for All Hours Worked, to Be Paid in Accordance With the Company’s Customary Payroll Procedures
12/34/56
EX-10.14
from S-1 5 pages March 5, 2024 Neil Abdollahian Re: Amended and Restated Employment Offer Letter Dear Neil: • Base Salary. From and After the Ipo, You Will Receive an Annual Base Salary Increase to the Annual Base Salary Rate Approved by the Board and Communicated to You in a Separate Compensation Memorandum, for All Hours Worked, to Be Paid in Accordance With the Company’s Customary Payroll Procedures
12/34/56
EX-10.13
from S-1 9 pages June 29, 2021 Neil Abdollahian Re: Employment Offer Letter Dear Neil: Boundless Bio, Inc. (The “Company”) Is Pleased to Offer You a Position on the Terms Set Forth in This Letter (This “Agreement”). • Base Salary. You Will Receive an Annual Base Salary of $350,000 for All Hours Worked, to Be Paid in Accordance With the Company’s Customary Payroll Procedures
12/34/56